PL204041A1 - Sposob wytwarzania nowych pochodnych 4"-aminooleandomycyny - Google Patents

Sposob wytwarzania nowych pochodnych 4"-aminooleandomycyny

Info

Publication number
PL204041A1
PL204041A1 PL20404178A PL20404178A PL204041A1 PL 204041 A1 PL204041 A1 PL 204041A1 PL 20404178 A PL20404178 A PL 20404178A PL 20404178 A PL20404178 A PL 20404178A PL 204041 A1 PL204041 A1 PL 204041A1
Authority
PL
Poland
Prior art keywords
aminooleandomycin
derivatives
making new
making
new
Prior art date
Application number
PL20404178A
Other languages
English (en)
Other versions
PL111160B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL204041A1 publication Critical patent/PL204041A1/pl
Publication of PL111160B1 publication Critical patent/PL111160B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1978204041A 1977-02-04 1978-01-17 Method of manufacture of novel derivatives of 4-aminooleandomycine PL111160B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/765,486 US4125705A (en) 1977-02-04 1977-02-04 Semi-synthetic 4-amino-oleandomycin derivatives

Publications (2)

Publication Number Publication Date
PL204041A1 true PL204041A1 (pl) 1979-06-04
PL111160B1 PL111160B1 (en) 1980-08-30

Family

ID=25073683

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1978216290A PL110793B1 (en) 1977-02-04 1978-01-17 Method of producing new oleandomycin
PL1978204041A PL111160B1 (en) 1977-02-04 1978-01-17 Method of manufacture of novel derivatives of 4-aminooleandomycine
PL1978216289A PL113163B1 (en) 1977-02-04 1978-01-17 Process for preparing novel derivatives of 4-aminooleandomycin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1978216290A PL110793B1 (en) 1977-02-04 1978-01-17 Method of producing new oleandomycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1978216289A PL113163B1 (en) 1977-02-04 1978-01-17 Process for preparing novel derivatives of 4-aminooleandomycin

Country Status (34)

Country Link
US (1) US4125705A (pl)
JP (2) JPS5398981A (pl)
AR (1) AR215666A1 (pl)
AT (1) AT358169B (pl)
AU (1) AU502293B1 (pl)
BE (1) BE863618A (pl)
BG (2) BG32116A3 (pl)
CA (1) CA1106366A (pl)
CH (1) CH629821A5 (pl)
CS (3) CS200536B2 (pl)
DD (1) DD134523A5 (pl)
DE (1) DE2804509C2 (pl)
DK (1) DK149628C (pl)
ES (1) ES465322A1 (pl)
FI (1) FI65262C (pl)
FR (2) FR2383964A1 (pl)
GB (1) GB1583921A (pl)
GR (1) GR68692B (pl)
HU (2) HU181395B (pl)
IE (1) IE46395B1 (pl)
IL (2) IL53959A0 (pl)
IT (1) IT1094211B (pl)
LU (1) LU79007A1 (pl)
NL (1) NL175997C (pl)
NO (2) NO145955C (pl)
NZ (1) NZ186384A (pl)
PH (2) PH14836A (pl)
PL (3) PL110793B1 (pl)
PT (1) PT67569B (pl)
RO (3) RO79258A (pl)
SE (2) SE445222B (pl)
SU (3) SU805949A3 (pl)
YU (3) YU39504B (pl)
ZA (1) ZA78646B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4363803A (en) * 1982-03-01 1982-12-14 Pfizer Inc. 3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use
US4413119A (en) * 1982-03-01 1983-11-01 Pfizer Inc. Semi-synthetic macrolides
JPH0240447U (pl) * 1988-09-14 1990-03-19
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH05155896A (ja) * 1991-01-18 1993-06-22 Yamanouchi Pharmaceut Co Ltd 新規マクロライド化合物及びその製造法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3022219A (en) * 1958-03-07 1962-02-20 Pfizer & Co C Acyl esters of oleandomycin
US3179652A (en) * 1961-09-05 1965-04-20 Pfizer & Co C Antibiotic recovery process and salts produced thereby
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives
US4036853A (en) * 1976-08-06 1977-07-19 Pfizer Inc. Semi-synthetic oleandomycin derivatives-C8 modifications

Also Published As

Publication number Publication date
IL53959A0 (en) 1978-04-30
YU39504B (en) 1984-12-31
PH16491A (en) 1983-10-28
PL113163B1 (en) 1980-11-29
NO150439C (no) 1984-10-17
NO780390L (no) 1978-08-07
PT67569A (en) 1978-02-01
NZ186384A (en) 1980-08-26
NO145955B (no) 1982-03-22
RO75387A (ro) 1980-11-30
YU300377A (en) 1982-10-31
FR2383964A1 (fr) 1978-10-13
GB1583921A (en) 1981-02-04
JPS5827799B2 (ja) 1983-06-11
NL7801259A (nl) 1978-08-08
HU181395B (en) 1983-07-28
NO145955C (no) 1982-06-30
ES465322A1 (es) 1978-09-16
AT358169B (de) 1980-08-25
AU502293B1 (en) 1979-07-19
SU805949A3 (ru) 1981-02-15
FR2396022A1 (fr) 1979-01-26
PT67569B (en) 1979-06-18
DD134523A5 (de) 1979-03-07
FR2383964B1 (pl) 1981-11-27
YU151782A (en) 1982-10-31
DK149628C (da) 1987-02-02
SE445222B (sv) 1986-06-09
BE863618A (fr) 1978-08-03
IE780240L (en) 1978-08-04
ATA72078A (de) 1980-01-15
PL111160B1 (en) 1980-08-30
SU888824A3 (ru) 1981-12-07
FI65262B (fi) 1983-12-30
RO79264A (ro) 1982-06-25
DE2804509C2 (de) 1982-12-02
BG32116A3 (en) 1982-05-14
PL110793B1 (en) 1980-07-31
IL61606A0 (en) 1981-01-30
YU39517B (en) 1984-12-31
IT7820006A0 (it) 1978-02-03
DK149628B (da) 1986-08-18
US4125705A (en) 1978-11-14
DE2804509A1 (de) 1978-08-10
NL175997C (nl) 1985-02-01
AR215666A1 (es) 1979-10-31
CS200538B2 (en) 1980-09-15
JPS56135497A (en) 1981-10-22
YU151882A (en) 1982-10-31
NL175997B (nl) 1984-09-03
NO811914L (no) 1978-08-07
FR2396022B1 (pl) 1980-06-13
GR68692B (pl) 1982-02-01
SU1020004A3 (ru) 1983-05-23
JPS5398981A (en) 1978-08-29
RO79258A (ro) 1982-06-25
SE7800269L (sv) 1978-08-05
IT1094211B (it) 1985-07-26
DK51778A (da) 1978-08-05
FI65262C (fi) 1984-04-10
FI780355A (fi) 1978-08-05
BG32117A4 (en) 1982-05-14
SE8300869D0 (sv) 1983-02-16
YU39518B (en) 1984-12-31
IE46395B1 (en) 1983-06-01
CS200536B2 (en) 1980-09-15
SE457085B (sv) 1988-11-28
CS200537B2 (en) 1980-09-15
JPS5652036B2 (pl) 1981-12-09
NO150439B (no) 1984-07-09
PH14836A (en) 1981-12-16
LU79007A1 (fr) 1979-09-06
ZA78646B (en) 1978-12-27
HU179744B (en) 1982-12-28
CH629821A5 (fr) 1982-05-14
CA1106366A (en) 1981-08-04

Similar Documents

Publication Publication Date Title
PL211753A1 (pl) Sposob wytwarzania nowych 1,1-dwuoksydo-4-hydroksy-2h-1,2-benzotiazyno-3-karboksyamidow
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL207766A1 (pl) Sposob wytwarzania nowych pochodnych peptydowych
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL206810A1 (pl) Sposob wytwarzania nowych pochodnych alkilenodwuaminy
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL204041A1 (pl) Sposob wytwarzania nowych pochodnych 4"-aminooleandomycyny
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL212389A1 (pl) Sposob alkilowania 4(5)-merkaptometylo-imidazoli
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL215005A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL206687A1 (pl) Sposob wytwarzania nowych pochodnych 4"-dezoksy-4"-sulfonylooleandomycyny
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL206451A1 (pl) Sposob wytwarzania kwasu 7 beta-chlorowcoarylomalonamido-7 alfa-metoksy-3-heterocyklotiometylo-1-detia-1-oksa-3-cefemokarboksylowego-4
PL206390A1 (pl) Sposob wytwarzania 2,4-dioksoheksahydro-1,3,5-triazyny
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
PL208406A1 (pl) Sposob wytwarzania pochodnych furokumaryny